Cardiovascular effects of ophthalmic 0.5% timolol aqueous solution and 0.1% timolol hydrogel

Clinical Physiology and Functional Imaging

Volumn 22, Issue 4, 2002, Pages 271-278

  Nino J ^a   Tahvanainen, K ^b   Uusitalo, H ^b   Turjanmaa, V ^a   Hutri Kahonen N ^b   Kaila, T ^b   Ropo, A ^d   Kuusela, T ^c   Kahonen M ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d NONE

Author keywords

Betablockers; Blood pressure; Electrocardiogram; Head up tilt; Heart rate

Indexed keywords

PLACEBO; TIMOLOL; EYE DROPS;

ADULT; AQUEOUS SOLUTION; ARTICLE; ATRIOVENTRICULAR CONDUCTION; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; ELECTROCARDIOGRAM; FEMALE; HEAD TILTING; HEART RATE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYDROGEL; HYPOTENSION; LUNG DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SUPINE POSITION; BLOOD; CARDIOVASCULAR SYSTEM; ELECTROCARDIOGRAPHY; OSMOLARITY;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYDROGELS; MALE; OPHTHALMIC SOLUTIONS; OSMOLAR CONCENTRATION; TIMOLOL;

EID: 0035996405     PISSN: 14750961     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1475-097X.2002.00430.x     Document Type: Article

References (42)

1. Timolol treatment of chronic open angle glaucoma and ocular hypertension. A 2-year multicenter study
2. Bradyarrhythmias secondary to the use of ophthalmic timolol. A report of 3 cases
3. Effects of topical β-blockers on cardiovascular function during exercise
4. Cardiovascular effects of topical betablockers during exercise
5. Role of the Frank-Starling mechanism in maintaining cardiac output during increased levels of tread-mill exercise in beta-blocked normal men
6. QT dispersion in patients with heart failure: β blockers are associated with a reduction in QT dispersion
7. Ocular β-blockers in glaucoma management - Clinical pharmacological aspects
8. Effect of atenolol and diltiazem on heart period variability in normal persons
9. Human responses to upright tilt: A window on central autonomic integration
10. Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men
11. Comparison of topical timolol vs betaxolol on cardiopulmonary excercise performance in healthy volunteers
12. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma
13. Effect of topical timolol maleate on exercise performance
14. Therapeutic equivalence of a tiinolol 0.1% hydrogel (T-GEL 0.1%) QD and aqueous timolol 0.5% BID in reducing the IOP of glaucomatous patients
15. A single scan algorithm for QRS-detection and feature extraction
16. Respiratory effects of timolol
17. Nocturnal hypotension: Role in glaucoma progression
18. Effect of beta-blockade with and without sympathomimetic activity (ISA) on sympathovagal balance and baroreflex sensitivity
19. Beta-blocker eyedrops and nocturnal arterial hypotension
20. Timolol: A review of its therapeutic efficacy in the topical treatment of glaucoma
21. Variation of respiratory sinus arrhythmia with age
22. Bazett's QT correction reviewed. Evidence that a linear QT correction for heart is better
23. The analysis of plasma kinetics and β-receptor binding and - Blocking activity of timolol following its small intravenous dose
24. Timolol: Long-term Canadian multicentre study
25. Cardiovascular effects of ophthalmic timolol
26. The normal electrocardiogram and vectorcardiogram
27. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985
28. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of symphatovagal interaction in man and conscious dog
29. Complete heart block after topical timolol
30. Numerical Recipes, Fourier Transform Spectral Methods
31. Dispersion of the QT-interval - A marker of therapeutic efficacy in the idiopathic long QT-syndrome
32. Third degree AV block due to ophthalmic timolol solution
33. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: A six-month, double-masked, multicenter study
34. Evaluation of once-daily levobunolol 0.25 % and timolol 0.25 % therapy for increased intra-ocular pressure
35. Spectral analysis of heart rate indicates reduced baroreceptor-related heart rate variability in elderly persons
36. Effect of atenolol or metoprolol on waking hour dynamics of the QT interval in myocardial infarction
37. Timolol ophthalmic solution and atrio-ventricular block syncope
38. The effects of cardio-selective and non-selective beta-adrenoreceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man
39. Heart rate variability. Standards of measurement, physiological interpretation and clinical use
40. SP353. Evaluation of efficacy and systemic side effects of topical 0.1% timolol gel and 0.5% aqueous timolol maleate
41. Long-term evaluation of timolol
42. Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic β-blockers on human cardiac vagal control